Augmentation Therapy for 1 -Antitrypsin Deficiency

Author： Georges S. Juvelekian   James K. Stoller  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.16, 2004-01, pp. : 1743-1756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alpha-1 Antitrypsin Deficiency: Treatment Beyond Augmentation Therapy

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 4, 2010-12 ,pp. : 330-335

Bentham Science Publishers

Access to resources Recommend Favorite

The promise of gene therapy for the treatment of αα-1 antitrypsin deficiency

By Cruz Pedro E   Mueller Christian   Flotte Terence R  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1191-1198

Future Medicine

Access to resources Recommend Favorite

Treatment of 1-antitrypsin deficiency is costly

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 309, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Treatment of 1-antitrypsin deficiency is costly

By  

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Flu vax not effective in α1-antitrypsin deficiency

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 547, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite